BGI Saves Genomics Technology

A large Chinese sequencing center’s purchase of Complete Genomics, a California-based DNA services company, ensures the valued technology will remain on the market.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Complete Genomics, a small biotech based in Mountain View, California, started sequencing genomes in 2009, using a technology that produced minimal errors in whole genome reads, catching the attention of many members of the scientific community. Despite this attention, the company suffered, losing $72.3 million in 2011. Earlier this month (September 17), the owner of the world’s largest sequencing facility, Chinese company BGI, announced its decision to spend $117.6 million to buy Complete Genomics’ shares and merge the two companies.

The buyout is being touted by researchers in the field as a welcome rescue to an important genomics technology in a field of dwindling choices. “Right now, Illumina would have a monopoly if Complete Genomics went under,” Michael Snyder, director of the Stanford Center for Genomics and Personalized Medicine, told Nature. Such competition is critical to keeping prices low and to ensure that the technology will continue to evolve, he ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio 
Zymo Research

Zymo Research Launches Microbiome Grant to Support Innovation in Microbial Sciences